Shenzhen Lifotronic Technology Co., Ltd. Stock Forum

Shenzhen Lifotronic Technology's low P/E ratio suggests slower expected growth. Stagnation in share price might follow unless earnings improve.

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...